THE EFFECT ON RESIDENT ATTITUDES OF REGULATORY POLICIES REGARDING PHARMACEUTICAL REPRESENTATIVE ACTIVITIES

被引:44
作者
BROTZMAN, GL
MARK, DH
机构
[1] the Department of Family and Community Medicine-Columbia Program, Medical College of Wisconsin, Milwaukee, Wisconsin
[2] the Department of Family and Community Medicine (DHM), Medical College of Wisconsin, Milwaukee, Wisconsin
关键词
RESIDENCY EDUCATION; PRIMARY CARE; PHARMACEUTICAL INDUSTRY; ETHICS;
D O I
10.1007/BF02599757
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To determine the effect on resident attitudes of policies regarding pharmaceutical representative interactions with residents. Design: Cross-sectional survey. Setting: National sample of U.S. family medicine residencies. Participants: Three hundred seventy-eight residents from 14 randomly selected programs. Seven programs had written policies and restrictions (restricted programs), and seven had no such restriction or guideline (free programs). Measurements and main results: The authors assessed resident attitudes regarding the perception of benefit from pharmaceutical representative activities, the usefulness of various sources of drug information, and the appropriateness of accepting gifts from a pharmaceutical representative. There were 265/378 respondents (70% response rate). Residents from restricted programs reported fewer benefits from pharmaceutical representative interactions and were less likely to feel that acceptance of gifts was appropriate. The amount of exposure to pharmaceutical representatives was positively correlated with perceived benefit and negatively correlated with ratings of appropriateness of gift acceptance. Conclusion: Regulatory policies can influence resident attitudes and perceptions. Training programs should develop written policies to help guide resident - pharmaceutical representative interactions.
引用
收藏
页码:130 / 134
页数:5
相关论文
共 9 条
[1]  
Scarpinato L., Pharmaceutical representatives (letter), J Gen Intern Med, 6, (1991)
[2]  
Physicians and the pharmaceutical industry, Ann Intern Med, 112, pp. 624-6, (1990)
[3]  
Miller K., Barza M., Curtis L., Et al., Undesirable marketing practices in the pharmaceutical industry, N Engl J Med, 313, (1985)
[4]  
Mick T., Pharmaceutical funding and medical students, JAMA, 265, (1991)
[5]  
Chren M., Landefeld S., Murray T., Doctors, drug companies, and gifts, JAMA, 262, pp. 3448-51, (1989)
[6]  
Lurie N., Rich E.C., Simpson D.E., Et al., Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff, J Gen Intern Med, 5, pp. 240-3, (1990)
[7]  
McKinney W.P., Schiedermayer D.L., Lurie N., Simpson D.E., Goodman J.L., Rich E.C., Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives, JAMA, 264, pp. 1693-7, (1990)
[8]  
Shaughnessy A.F., Drug promotion in a family medicine training center, JAMA, 260, (1988)
[9]  
Brotzman G.L., Mark D.H., Policies regulating the activities of pharmaceutical representatives in residency programs, J Fam Pract, 34, pp. 54-7, (1992)